Skip to main content
padlock icon - secure page this page is secure

Free Content Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis [Perspectives]

Download Article:
(PDF 324.2 kb)
Human immunodeficiency virus (HIV) infection increases the risk of tuberculosis (TB) 21–34 fold, and has fuelled the resurgence of TB in sub-Saharan Africa. The World Health Organization (WHO) recommends the Three I's for HIV/TB (infection control, intensified case finding [ICF] and isoniazid preventive therapy) and earlier initiation of antiretroviral therapy for preventing TB in persons with HIV. Current service delivery frameworks do not identify people early enough to maximally harness the preventive benefits of these interventions. Community-based campaigns were essential components of global efforts to control major public health threats such as polio, measles, guinea worm disease and smallpox. They were also successful in helping to control TB in resource-rich settings. There have been recent community-based efforts to identify persons who have TB and/or HIV. Multi-disease community-based frameworks have been rare. Based on findings from a WHO meta-analysis and a Cochrane review, integrating ICF into the recent multi-disease prevention campaign in Kenya may have had implications in controlling TB. Community-based multi-disease prevention campaigns represent a potentially powerful strategy to deliver prevention interventions, identify people with HIV and/or TB, and link those eligible to care and treatment.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: HIV; campaign; community; control; tuberculosis

Document Type: Research Article

Affiliations: 1: Department of HIV/AIDS, World Health Organization, Geneva, Switzerland 2: KNCV Tuberculosis Foundation, The Hague, The Netherlands 3: Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland 4: Vestergaard-Frandsen Inc., Lausanne, Switzerland 5: Independent Consultant, UK 6: Division of Leprosy TB and Lung Disease, Kenya Ministry of Public Health and Sanitation, Nairobi, Kenya 7: Stop TB Department, World Health Organization, Geneva, Switzerland 8: South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa

Publication date: 01 April 2012

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more